Stock Events

Everest Medicines Limited 

HK$20.95
0
+HK$0+0% Today

Statistics

Day High
21.5
Day Low
19.72
52W High
32.2
52W Low
10.32
Volume
3,118,717
Avg. Volume
2,966,839
Mkt Cap
4.1B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

4MarExpected
Q2 2023
Next
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 1952.HK. It's not an investment recommendation.

About

Everest Medicines Limited, a biopharmaceutical company, engages in discovery, licensing, clinical development, and commercialization of therapies to address critical unmet medical needs in Greater China and other Asia Pacific markets. Its pipeline products include eleven clinical-stage drug candidates for the treatment of oncology, immunology, cardio-renal, and infectious diseases. Everest Medicines Limited was incorporated in 2017 and is headquartered in Shanghai, China.
Show more...
CEO
Mr. Wei Fu
Employees
476
Country
Hong Kong
ISIN
KYG3224E1061
WKN
000A2QD66

Listings